Hypercoagulable State Associated with COVID-19 Infection

IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.

Thursday, November 12, 2020
12:00 PM ET/9:00 AM PT

At the conclusion of this program, participants will be able to:
• Identify key coagulation markers that are associated with increased mortality in COVID-19 infected patients
• Distinguish COVID-19 hypercoagulability from other hypercoagulable states
• Understand key laboratory issues associated with thrombophilia testing and anticoagulant monitoring in patients with COVID-19 infection
Presented by:
Edward C. C. Wong, MD
Medical Director, Quest Diagnostics; Adj Assoc Professor, George Washington School of Medicine and Health Sciences; Clinical Consultant, Children’s National Hospital
Moderated by:
Frederick K. Racke, MD, PhD
Medical Director Hematology/Oncology and Coagulation Quest Diagnostics

INVITATION - Download printable invitation PDF